Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Markatseli, T. E."'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Papamichail, G. V., Georgiadis, A. N., Tellis, C. C., Rapti, I., Markatseli, T. E., Xydis, V. G., Tselepis, A. D., Drosos, A. A., Voulgari, P. V.
Publikováno v:
Clinical Rheumatology; Jan2024, Vol. 43 Issue 1, p481-488, 8p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Boussios, Stergios, Pentheroudakis, George, Somarakis, G., Markatseli, T. E., Drosos, Alexandros A., Pavlidis, Nicholas
Publikováno v:
Anticancer Research
Background: With the development of modern therapies and better care of patients with autoimmune rheumatic diseases (ARDs) increased survival has been achieved. However, ARDs may share an association with risk of lymphomas and solid tumors. The incre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______4485::153f9999b5e4cbc7909dbc92e08e1d2a
https://gnosis.library.ucy.ac.cy/handle/7/41417
https://gnosis.library.ucy.ac.cy/handle/7/41417
OBJECTIVES: To investigate the efficacy, safety and survival of tumour necrosis factor (TNF) alpha antagonists in patients with rheumatoid arthritis (RA). METHODS: One hundred and fifty-one RA patients treated with TNF-alpha inhibitors during the tim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_____10561::17febf8558786f7f6a1ffefa5992fe5a
http://olympias.lib.uoi.gr/jspui/handle/123456789/17949
http://olympias.lib.uoi.gr/jspui/handle/123456789/17949
OBJECTIVE: To investigate the efficacy, toxicity, and drug discontinuation in patients with psoriatic arthritis treated with anti-tumor necrosis factor agents. METHODS: Sixty-five patients with active disease were included in this open-label study. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_____10561::7e4df9aa446597766f1e06b2d61c6916
http://olympias.lib.uoi.gr/jspui/handle/123456789/24779
http://olympias.lib.uoi.gr/jspui/handle/123456789/24779
OBJECTIVE: to describe the longterm clinical and radiological outcomes in rheumatoid arthritis (RA) in a cohort in northwestern Greece; and to investigate predictive factors of radiological damage at the 10-year followup in patients with RA. METHODS:
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_____10561::a05e1de7ff56d965bcb60a8b87e6a8b2
http://olympias.lib.uoi.gr/jspui/handle/123456789/19019
http://olympias.lib.uoi.gr/jspui/handle/123456789/19019
This report seeks to describe the clinical efficacy and safety of infliximab in a patient with psoriatic arthritis on hemodialysis and to review the literature on the topic. We present a patient with psoriatic arthritis on hemodialysis treated with i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_____10561::25574f69ed1f2efe403f3d143a20f8aa
http://olympias.lib.uoi.gr/jspui/handle/123456789/24388
http://olympias.lib.uoi.gr/jspui/handle/123456789/24388
Rituximab is a chimeric monoclonal therapeutic antibody which causes depletion of CD20-positive B cells. Apart from its apparent efficacy in the treatment of non-Hodgkin lymphoma and of several rheumatic diseases, it is associated with adverse events
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_____10561::68c1f2e9f8ff477484f0120e9954f14a
http://olympias.lib.uoi.gr/jspui/handle/123456789/20815
http://olympias.lib.uoi.gr/jspui/handle/123456789/20815